Clinical Trials Directory

Trials / Completed

CompletedNCT02881892

Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

Interleukin-6, Procalcitonin and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate With Peritoneal Solute Transport and Dialysis Adequacy in CAPD Patients

Status
Completed
Phase
Study type
Observational
Enrollment
26 (actual)
Sponsor
Bangkok Metropolitan Administration Medical College and Vajira Hospital · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of study was to evaluated the correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Detailed description

This cross -sectional study measured IL-6, procalcitonin and VEGF level in plasma and overnight effluent. PSTR of small solutes was evaluated by standard peritoneal equilibration test (standard PET). Weekly Kt/V and creatinine clearance (CCr ) were evaluated in all patients.

Conditions

Interventions

TypeNameDescription
OTHERMeasure plasma and dialysate level of IL-6, procalcitonin and VEGFcorrelation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Timeline

Start date
2012-03-01
Primary completion
2014-05-01
Completion
2014-06-01
First posted
2016-08-29
Last updated
2016-08-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02881892. Inclusion in this directory is not an endorsement.